Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
120M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-1.4M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$2.04M
-
Number of sells
-
-16
Significant Holders of Tiziana Life Sciences Ltd - Common (TLSA) as of Q4 2021
18 filings reported holding TLSA - Tiziana Life Sciences Ltd - Common as of Q4 2021.
Tiziana Life Sciences Ltd - Common (TLSA) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 120M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include EATON VANCE MANAGEMENT (0 shares), Platform Technology Partners (0 shares), Spire Wealth Management (0 shares), Capital Asset Advisory Services LLC (0 shares), Ausdal Financial Partners, Inc. (0 shares), STATE STREET CORP (0 shares), MORGAN STANLEY (0 shares), GROUP ONE TRADING, L.P. (0 shares), BANK OF AMERICA CORP /DE/ (0 shares), and MARSHALL WACE, LLP (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.